These findings imply that P111, P121, or LpBL are able to suppress lipogenesis and induce lipolysis in the liver and intestine by inducing AMPK activation and SIRT1 expression, leading to the alleviation of liver steatosis. The gene discussed is SIRT1; the disease is fatty liver disease.